CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
An introduction of the Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) Project
Na-Young Jeong, Hae-In Lee, Min-Ju Kim, Hee-Jin Kim, Nam-Kyong Choi
J Health Info Stat. 2021;46(4):369-377.   Published online 2021 November 30    DOI: https://doi.org/10.21032/jhis.2021.46.4.369

Excel Download

An introduction of the Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) Project
Journal of Health Informatics and Statistics. 2021;46(4):369-377   Crossref logo
Link1 Link2 Link3

Project aims to advance vaccine benefit:risk assessment in Europe
Reactions Weekly. 2013;1482(1):2-2   Crossref logo
Link1 Link2 Link3

Risk-benefit analysis of emergency vaccine use
Scientific Reports. 2022;12(1):   Crossref logo
Link1 Link2 Link3

The Brighton Collaboration standardized templates for collection of key information for benefit-risk assessment of vaccines by technology (BRAVATO; formerly V3SWG)
Vaccine. 2021;39(22):3050-3052   Crossref logo
Link1 Link2

A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273)
Vaccine. 2022;   Crossref logo
Link1 Link2

A risk–benefit analysis of vaccination
Vaccine. 2009;27:G9-G12   Crossref logo
Link1 Link2

Introduction
Cost-Benefit Analysis for Project Appraisal. 2015;1-8   Crossref logo
Link1

Advancing collaborative vaccine benefits and safety research in Europe via the ADVANCE code of conduct
Vaccine. 2018;36(2):194-195   Crossref logo
Link1 Link2

WITHDRAWN: Dengue Human Infection Models to Advance Dengue Vaccine Development
Vaccine. 2015;   Crossref logo
Link1 Link2

Selective risk group strategies in Europe
Vaccine. 1995;13:S44-S46   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. J Health Info Stat has participated in CrossRef Text and Data Mining service since March 1, 2016.